Advertisement

Index by author

June 01, 1988; Volume 33,Issue 6

A

  1. Ahir, S

    1. Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

  2. Akita, Y

    1. Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
      Y Yajima, Y Akita and T Saito
      Molecular Pharmacology June 1988, 33 (6) 592-597;

  3. Altar, C A

    1. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;

B

  1. Baker, D C

    1. Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

  2. Beall, P

    1. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;

  3. Berner, B

    1. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;

  4. Blanton, M

    1. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;

  5. Borchardt, R T

    1. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;

  6. Borcherding, D R

    1. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;

  7. Boyar, W C

    1. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;

  8. Brown, A M

    1. Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
      J Donaldson, S J Hill and A M Brown
      Molecular Pharmacology June 1988, 33 (6) 626-633;

C

  1. Carlsen, S F

    1. Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonists.
      C A Altar, B Berner, P Beall, S F Carlsen and W C Boyar
      Molecular Pharmacology June 1988, 33 (6) 690-695;

  2. Casida, J E

    1. Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;

  3. Chijiwa, T

    1. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

  4. Christova, T Y

    1. Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
      F Orosz, T Y Christova and J Ovádi
      Molecular Pharmacology June 1988, 33 (6) 678-682;

  5. Cragoe, E J

    1. Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;

  6. Craig, R H

    1. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;

  7. Crooks, P A

    1. Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;

D

  1. Daluge, S M

    1. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;

  2. Damani, L A

    1. Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;

  3. Danilowicz, R M

    1. Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
      R D Nolan, R M Danilowicz and T E Eling
      Molecular Pharmacology June 1988, 33 (6) 650-656;

  4. Darchen, F

    1. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;

  5. Donaldson, J

    1. Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
      J Donaldson, S J Hill and A M Brown
      Molecular Pharmacology June 1988, 33 (6) 626-633;

E

  1. Eling, T E

    1. Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
      R D Nolan, R M Danilowicz and T E Eling
      Molecular Pharmacology June 1988, 33 (6) 650-656;

G

  1. Gallaher, T

    1. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;

  2. Garay, R P

    1. Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;

  3. Giraldo, E

    1. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;

  4. Graziano, M J

    1. Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;

H

  1. Hagiwara, M

    1. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

  2. Hammer, R

    1. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;

  3. Hannaert, P A

    1. Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;

  4. Hartzell, H C

    1. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
      M A Simmons and H C Hartzell
      Molecular Pharmacology June 1988, 33 (6) 664-671;

  5. Hasobe, M

    1. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;

  6. Henry, J P

    1. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;

  7. Hidaka, H

    1. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

  8. Hill, S J

    1. Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices.
      J Donaldson, S J Hill and A M Brown
      Molecular Pharmacology June 1988, 33 (6) 626-633;

  9. Hixon, J

    1. Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;

  10. Humphreys, C J

    1. Antidepressant binding to the porcine and human platelet serotonin transporters.
      C J Humphreys, J Levin and G Rudnick
      Molecular Pharmacology June 1988, 33 (6) 657-663;

I

  1. Ishikawa, T

    1. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

J

  1. James, I F

    1. Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;

  2. Jiang, C

    1. Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

K

  1. Kaderlik, R K

    1. Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;

  2. Keller, B T

    1. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;

L

  1. Ladinsky, H

    1. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;

  2. Laduron, P M

    1. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;

  3. Levin, J

    1. Antidepressant binding to the porcine and human platelet serotonin transporters.
      C J Humphreys, J Levin and G Rudnick
      Molecular Pharmacology June 1988, 33 (6) 657-663;

  4. Linden, J

    1. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;

M

  1. Malinowski, N

    1. Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

  2. Mamiya, S

    1. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

  3. Matsuzawa, M

    1. Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;

  4. McCardy, E

    1. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;

  5. Mckee, J G

    1. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
      M Hasobe, J G Mckee, D R Borcherding, B T Keller and R T Borchardt
      Molecular Pharmacology June 1988, 33 (6) 713-720;

  6. Miller, R J

    1. Multiple sites for the regulation of the N-methyl-D-aspartate receptor.
      I J Reynolds and R J Miller
      Molecular Pharmacology June 1988, 33 (6) 581-584;

  7. Moyer, J D

    1. Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

N

  1. Nakamura, S

    1. Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
      S Nakamura, K Ohmi and Y Nonomura
      Molecular Pharmacology June 1988, 33 (6) 604-610;

  2. Nazaret, C

    1. Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
      R P Garay, C Nazaret, P A Hannaert and E J Cragoe
      Molecular Pharmacology June 1988, 33 (6) 696-701;

  3. Nolan, R D

    1. Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.
      R D Nolan, R M Danilowicz and T E Eling
      Molecular Pharmacology June 1988, 33 (6) 650-656;

  4. Nonomura, Y

    1. Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
      S Nakamura, K Ohmi and Y Nonomura
      Molecular Pharmacology June 1988, 33 (6) 604-610;

O

  1. Ohmi, K

    1. Low concentration of reserpine accelerates actin polymerization via interaction with G-actin.
      S Nakamura, K Ohmi and Y Nonomura
      Molecular Pharmacology June 1988, 33 (6) 604-610;

  2. Orosz, F

    1. Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
      F Orosz, T Y Christova and J Ovádi
      Molecular Pharmacology June 1988, 33 (6) 678-682;

  3. Ovádi, J

    1. Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes.
      F Orosz, T Y Christova and J Ovádi
      Molecular Pharmacology June 1988, 33 (6) 678-682;

P

  1. Patel, A

    1. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
      A Patel, R H Craig, S M Daluge and J Linden
      Molecular Pharmacology June 1988, 33 (6) 585-591;

  2. Pessah, I N

    1. Partial characterization of specific cantharidin binding sites in mouse tissues.
      M J Graziano, I N Pessah, M Matsuzawa and J E Casida
      Molecular Pharmacology June 1988, 33 (6) 706-712;

  3. Pool, W F

    1. Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;

R

  1. Reizes, O

    1. Substrate properties of analogs of myo-inositol.
      J D Moyer, O Reizes, S Ahir, C Jiang, N Malinowski and D C Baker
      Molecular Pharmacology June 1988, 33 (6) 683-689;

  2. Reynolds, I J

    1. Multiple sites for the regulation of the N-methyl-D-aspartate receptor.
      I J Reynolds and R J Miller
      Molecular Pharmacology June 1988, 33 (6) 581-584;

  3. Rosenberg, J

    1. Messenger RNA loses the ability to direct in vitro peptide synthesis following incubation with cisplatin.
      J Rosenberg and P Sato
      Molecular Pharmacology June 1988, 33 (6) 611-616;

  4. Rudnick, G

    1. Antidepressant binding to the porcine and human platelet serotonin transporters.
      C J Humphreys, J Levin and G Rudnick
      Molecular Pharmacology June 1988, 33 (6) 657-663;

S

  1. Saito, T

    1. Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
      Y Yajima, Y Akita and T Saito
      Molecular Pharmacology June 1988, 33 (6) 592-597;

  2. Saitoh, M

    1. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation.
      T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya, M Saitoh and H Hidaka
      Molecular Pharmacology June 1988, 33 (6) 598-603;

  3. Sato, P

    1. Messenger RNA loses the ability to direct in vitro peptide synthesis following incubation with cisplatin.
      J Rosenberg and P Sato
      Molecular Pharmacology June 1988, 33 (6) 611-616;

  4. Scherman, D

    1. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles.
      F Darchen, D Scherman, P M Laduron and J P Henry
      Molecular Pharmacology June 1988, 33 (6) 672-677;

  5. Simmons, M A

    1. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
      M A Simmons and H C Hartzell
      Molecular Pharmacology June 1988, 33 (6) 664-671;

V

  1. Viganò, M A

    1. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
      E Giraldo, M A Viganò, R Hammer and H Ladinsky
      Molecular Pharmacology June 1988, 33 (6) 617-625;

W

  1. Walpole, C S

    1. Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;

  2. Wang, H H

    1. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
      M Blanton, E McCardy, T Gallaher and H H Wang
      Molecular Pharmacology June 1988, 33 (6) 634-642;

  3. Wood, J N

    1. Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;

  4. Wrigglesworth, R

    1. Long-lasting agonist activity produced by a capsaicin-like photoaffinity probe.
      I F James, C S Walpole, J Hixon, J N Wood and R Wrigglesworth
      Molecular Pharmacology June 1988, 33 (6) 643-649;

Y

  1. Yajima, Y

    1. Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells.
      Y Yajima, Y Akita and T Saito
      Molecular Pharmacology June 1988, 33 (6) 592-597;

Z

  1. Ziegler, D M

    1. Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase.
      L A Damani, W F Pool, P A Crooks, R K Kaderlik and D M Ziegler
      Molecular Pharmacology June 1988, 33 (6) 702-705;
Back to top

In this issue

Advertisement